The mitogenic growth factors FGF1 and FGF2, known to possess potent angiogenic properties47,48, were increased in patients with malignant breast tumours and decreased in patients with benign breast lesions indicating their possible role in malignant cell transformation. Here, FGF2 is linked to breast cancer.